Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kyle Crassini, Yandong Shen, Stephen Mulligan & O. Giles Best. (2017) Modeling the chronic lymphocytic leukemia microenvironment in vitro. Leukemia & Lymphoma 58:2, pages 266-279.
Read now
Read now
Rachel E. Hayden, Racha Kussaibati, Laura M. Cronin, Guy Pratt, Claudia Roberts, Mark T. Drayson & Christopher M. Bunce. (2015) Bezafibrate and medroxyprogesterone acetate target resting and CD40L-stimulated primary marginal zone lymphoma and show promise in indolent B-cell non-Hodgkin lymphomas. Leukemia & Lymphoma 56:4, pages 1079-1087.
Read now
Read now
Articles from other publishers (23)
Jack G. Fisher, Amber D. P. Doyle, Lara V. Graham, Shreyanshi Sonar, Ben Sale, Isla Henderson, Luis Del Rio, Peter W. M. Johnson, Yosef Landesman, Mark S. Cragg, Francesco Forconi, Christopher J. Walker, Salim. I. Khakoo & Matthew D. Blunt. (2023) XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression. Leukemia.
Crossref
Crossref
Nina Verstraete, Malvina Marku, Marcin Domagala, Hélène Arduin, Julie Bordenave, Jean-Jacques Fournié, Loïc Ysebaert, Mary Poupot & Vera Pancaldi. (2023) An agent-based model of monocyte differentiation into tumour-associated macrophages in chronic lymphocytic leukemia. iScience 26:6, pages 106897.
Crossref
Crossref
Peter‐Martin Bruch, Holly AR Giles, Carolin Kolb, Sophie A Herbst, Tina Becirovic, Tobias Roider, Junyan Lu, Sebastian Scheinost, Lena Wagner, Jennifer Huellein, Ivan Berest, Mark Kriegsmann, Katharina Kriegsmann, Christiane Zgorzelski, Peter Dreger, Judith B Zaugg, Carsten Müller‐Tidow, Thorsten Zenz, Wolfgang Huber & Sascha Dietrich. (2022)
Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in
CLL
. Molecular Systems Biology 18:8.
Crossref
Crossref
Thomas A. Burley, Andrew Hesketh, Giselda Bucca, Emma Kennedy, Eleni E. Ladikou, Benjamin P. Towler, Simon Mitchell, Colin P. Smith, Christopher Fegan, Rosalynd Johnston, Andrea Pepper & Chris Pepper. (2022) Elucidation of Focal Adhesion Kinase as a Modulator of Migration and Invasion and as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia. Cancers 14:7, pages 1600.
Crossref
Crossref
Makhloufi Zoulikha & Wei He. (2022) Targeted Drug Delivery for Chronic Lymphocytic Leukemia. Pharmaceutical Research 39:3, pages 441-461.
Crossref
Crossref
Carlos Cuesta-Mateos, Fernando Terrón & Marco Herling. (2021) CCR7 in Blood Cancers – Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target. Frontiers in Oncology 11.
Crossref
Crossref
Carlos Cuesta-Mateos, Jennifer R. Brown, Fernando Terrón & Cecilia Muñoz-Calleja. (2021) Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target. Frontiers in Immunology 12.
Crossref
Crossref
Xue Yan Cui, Geir Erland Tjønnfjord, Sandip M. Kanse, Anders Erik Astrup Dahm, Nina Iversen, Christiane Filion Myklebust, Ling Sun, Zhong Xing Jiang, Thor Ueland, James J. Campbell, Mitchell Ho & Per Morten Sandset. (2021) Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia. Scientific Reports 11:1.
Crossref
Crossref
Nagaja Capitani, Giulia Lori, Paolo Paoli, Laura Patrussi, Arianna Troilo, Cosima T. Baldari, Giovanni Raugei & Mario Milco D’Elios. (2019) LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy. Cancer Cell International 19:1.
Crossref
Crossref
A Guo, P Lu, J Lee, C Zhen, G Chiosis & Y L Wang. (2017) HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironment. Oncogene 36:24, pages 3441-3449.
Crossref
Crossref
Danny Bousmail, Lilian Amrein, Johans J. Fakhoury, Hassan H. Fakih, John C. C. Hsu, Lawrence Panasci & Hanadi F. Sleiman. (2017) Precision spherical nucleic acids for delivery of anticancer drugs. Chemical Science 8:9, pages 6218-6229.
Crossref
Crossref
M Larrayoz, S J Blakemore, R C Dobson, M D Blunt, M J J Rose-Zerilli, R Walewska, A Duncombe, D Oscier, K Koide, F Forconi, G Packham, M Yoshida, M S Cragg, J C Strefford & A J Steele. (2015) The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1. Leukemia 30:2, pages 351-360.
Crossref
Crossref
K M Koczula, C Ludwig, R Hayden, L Cronin, G Pratt, H Parry, D Tennant, M Drayson, C M Bunce, F L Khanim & U L Günther. (2015) Metabolic plasticity in CLL: adaptation to the hypoxic niche. Leukemia 30:1, pages 65-73.
Crossref
Crossref
Fanny LafouresseElisabeth BellardCamille Laurent, Christine MoussionJean-Jacques FourniéLoïc Ysebaert & Jean-Philippe Girard. (2015) L-selectin controls trafficking of chronic lymphocytic leukemia cells in lymph node high endothelial venules in vivo. Blood 126:11, pages 1336-1345.
Crossref
Crossref
Alexandre JanelFrédérique Dubois-GalopinCéline BourgneJuliette BergerKarin TarteNathalie Boiret-DupréStéphane BoisgardPierre VerrellePierre DéchelotteOlivier TournilhacMarc G. Berger. (2014) The Chronic Lymphocytic Leukemia Clone Disrupts the Bone Marrow Microenvironment. Stem Cells and Development 23:24, pages 2972-2982.
Crossref
Crossref
B.D. Hock, S.A. Macpherson, L.J. Fernyhough & J.L. McKenzie. (2014) Chronic lymphocytic leukaemia cells become both activated and immunosuppressive following interaction with CD3 and CD28 stimulated PBMC. Leukemia Research 38:10, pages 1217-1223.
Crossref
Crossref
. 2014. Primer to the Immune Response. Primer to the Immune Response
553
585
.
Melinda Burgess, Devinder Gill, Richa Singhania, Catherine Cheung, Lynne Chambers, Brent A. Renyolds, Louise Smith, Peter Mollee, Nicholas Saunders & Nigel AJ McMillan. (2013) CD62L as a Therapeutic Target in Chronic Lymphocytic Leukemia. Clinical Cancer Research 19:20, pages 5675-5685.
Crossref
Crossref
Alan D. Ramsay & Manuel Rodriguez‐Justo. (2013) Chronic lymphocytic leukaemia – the role of the microenvironment pathogenesis and therapy. British Journal of Haematology 162:1, pages 15-24.
Crossref
Crossref
Lilian Amrein, May Shawi, Jeremy Grenier, Raquel Aloyz & Lawrence Panasci. (2013)
The phosphatidylinositol‐3 kinase I inhibitor BKM120 induces cell death in B‐chronic lymphocytic leukemia cells
in vitro
. International Journal of Cancer 133:1, pages 247-252.
Crossref
Crossref
Shih-Shih Chen, Franak BatliwallaNichol E. HolodickXiao-Jie Yan, Sophia Yancopoulos, Carlo M. Croce, Thomas L. Rothstein & Nicholas Chiorazzi. (2013) Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling. Proceedings of the National Academy of Sciences 110:16.
Crossref
Crossref
Barry D. Hock, Liam J. Fernyhough, Sheryl M. Gough & Judith L. McKenzie. (2013) Clinical Significance of Plasma Levels of Soluble CD40 in Patients with Chronic Lymphocytic Leukemia. Open Journal of Blood Diseases 03:01, pages 1-5.
Crossref
Crossref
Alessandro Natoni, Michael O’Dwyer & Corrado Santocanale. 2013. Target Identification and Validation in Drug Discovery. Target Identification and Validation in Drug Discovery
217
226
.